In the B16F10 melanoma mouse model, IRF8 was shown to be downregulated in bone-marrow-derived myeloid cells in an ID1-dependent fashion by tumor-derived soluble factors, most notably TGF-β [10]. Here, IRF8 is linked to melanoma.